A comparison of Seroquel vs. Risperidone in Schizophrenia

Study identifier:5077US/0043

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

-

Medical condition

schizophrenia

Phase

Phase 4

Healthy volunteers

No

Study drug

quetiapine fumarate vs risperidone

Sex

All

Actual Enrollment

-

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 Jul 2001
Primary Completion Date: 01 Sept 2002
Study Completion Date: 01 Sept 2002

Study design

Allocation: None
Endpoint Classification: None
Intervention Model: None
Masking: None
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria